SALT LAKE CITY, March 31, 2021 /PRNewswire/ — The CEO of Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, appeared yesterday on Yahoo! Finance to comment on the Company’s recently-released FY2020 earnings report, and to discuss its going-forward strategy as the world struggles to achieve normalization. Co-Diagnostics CEO Dwight Egan remarked, “We believe that the future of gold-standard PCR… Source link
Read More »Co-Diagnostics, Inc. CEO Discusses Company Strategy for the Future with Yahoo! Finance
TipRanks 2 “Strong Buy” Penny Stocks That Could Go Boom Arguably the most controversial on the Street, penny stocks are a hot-button issue. Usually, there isn’t a lot of middle-ground with respect to these tickers priced for less than $5 apiece. Dividing market watchers into two distinct groups, both sides present valid arguments laying out the pros and cons. Sure, there is reason enough to be skeptical. Often, a cheap stock is cheap for a reason, with the low share price potentially… Source link
Read More »Co-Diagnostics, Inc. CEO Discusses Company Strategy for the Future with Yahoo! Finance | National News
SALT LAKE CITY, March 31, 2021 /PRNewswire/ — The CEO of Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, appeared yesterday on Yahoo! Finance to comment on the Company’s recently-released FY2020 earnings report, and to discuss its going-forward strategy as the world struggles to achieve normalization. Co-Diagnostics CEO Dwight Egan remarked, “We believe that the… Source link
Read More »